Skip to main content
HR 6101 117th Congress House

Drug Price Transparency in Medicaid Act of 2021

Official title: To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.

Introduced: March 17, 2022 Introduced by: Carter, Earl L. "Buddy" Republican · Georgia See on congress.gov
Health Business recordsCongressional oversightGovernment information and archivesHealth care costs and insurance
More subjectsShow fewer subjects
Home and outpatient careInflation and pricesMedicaidPrescription drugsPublic contracts and procurementRetail and wholesale tradesState and local government operationsUser charges and fees
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 2, 2021
Referred to the Subcommittee on Health.
Dec 1, 2021
Referred to the House Committee on Energy and Commerce.
Dec 1, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 2, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Drug Price Transparency in Medicaid Act of 2021

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Democratic 1 Republican 1
R
Meuser, Daniel
Pennsylvania · Mar 17, 2022
Jacobs, Chris
· Feb 9, 2022
Carl, Jerry
· Jan 11, 2022
 D
Gonzalez, Vicente
Texas · Dec 1, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6101: Drug Price Transparency in Medicaid Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6101/
MLA
"H.R. 6101: Drug Price Transparency in Medicaid Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6101/.
Bluebook (legal)
H.R. 6101, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6101/.
Markdown link
[H.R. 6101: Drug Price Transparency in Medicaid Act of 2021](https://openamerica.io/bill/117-HR-6101/)
Report a problem